>Mercado de detección de salud de Asia y el Pacífico, por tipo de prueba (pruebas de colesterol, prueba de diabetes , detección de cáncer, prueba de revisión general, ETS, prueba de presión arterial y otras), tipo de paquete (examen de salud básico, perfil de la tercera edad, control de salud de la mujer, control de salud del hombre, control cardíaco , control de diabetes y otros), tipo de panel (paneles de múltiples pruebas y paneles de una sola prueba), tipo de muestra (sangre, orina, suero , saliva y otros), tecnología (inmunoensayos, imágenes médicas, QPCR (reacción en cadena de la polimerasa cuantitativa), Q-FISH (fluorescencia cuantitativa, hibridación in situ), TRF (fragmento de restricción terminal), STELA (análisis de longitud de telómero único) y otros), condición (enfermedad cardiovascular, trastornos metabólicos, cáncer, afecciones inflamatorias, trastornos musculoesqueléticos, afecciones neurológicas, complicaciones de la hepatitis C, afecciones relacionadas con la inmunología y Otros), Sitios de Recolección de Muestras (Hospitales, Hogares, Laboratorios de Diagnóstico, Oficinas y Otros), Canal de Distribución (Licitaciones Directas, Ventas Minoristas y Otros), País (Japón, China, Corea del Sur, India, Australia, Singapur, Tailandia, Malasia, Indonesia, Filipinas, Vietnam, Resto de Asia-Pacífico), Tendencias de la Industria y Pronóstico hasta 2028.
Análisis y perspectivas del mercado: mercado de detección de enfermedades en Asia y el Pacífico
Se espera que el mercado de detección de salud de Asia y el Pacífico gane crecimiento de mercado en el período de pronóstico de 2021 a 2028. Data Bridge Market Research analiza que el mercado está creciendo con una CAGR del 13,6% en el período de pronóstico de 2021 a 2028 y se espera que alcance los USD 109.704,00 millones para 2028. El creciente número de enfermedades crónicas, la población geriátrica y la creciente conciencia sobre la detección temprana y el tratamiento de enfermedades son los principales impulsores que impulsaron la demanda del mercado en el período de pronóstico.
El examen de salud es un método importante para la detección temprana de un trastorno específico. Las pruebas de detección se utilizan a menudo en la medicina preventiva para identificar si una persona muestra signos tempranos de los factores de riesgo de una afección. Las enfermedades que pueden detectarse mediante el examen incluyen cáncer, diabetes, colesterol alto, presión arterial alta y osteoporosis.
La creciente concienciación de la población sobre la detección temprana y el tratamiento de enfermedades y el incremento del gasto sanitario están incrementando la demanda de exámenes médicos.
La creciente demanda de pruebas de detección de la salud debido a su eficacia, junto con el creciente número de proveedores de servicios y la creciente campaña de concienciación de los actores privados y públicos sobre las pruebas de detección de la salud, están impulsando el crecimiento del mercado de pruebas de detección de la salud en el período de pronóstico. Sin embargo, el alto costo de las pruebas de detección puede obstaculizar el crecimiento del mercado en el período de pronóstico.
El informe del mercado de detección de salud de Asia y el Pacífico proporciona detalles sobre la participación de mercado, los nuevos desarrollos y el análisis de la cartera de productos, el impacto de los actores del mercado nacional y localizado, analiza las oportunidades en términos de bolsas de ingresos emergentes, cambios en las regulaciones del mercado, aprobaciones de productos, decisiones estratégicas, lanzamientos de productos, expansiones geográficas e innovaciones tecnológicas en el mercado. Para comprender el análisis y el escenario del mercado, contáctenos para obtener un resumen de analista; nuestro equipo lo ayudará a crear una solución de impacto en los ingresos para lograr su objetivo deseado.
Alcance y tamaño del mercado de detección de salud en Asia y el Pacífico
El mercado de detección de enfermedades de Asia y el Pacífico está segmentado en ocho segmentos importantes según el tipo de prueba, el tipo de paquete, el tipo de panel, el tipo de muestra, la tecnología, la condición, los sitios de recolección de muestras y el canal de distribución. El crecimiento entre segmentos le ayuda a analizar nichos de crecimiento y estrategias para abordar el mercado y determinar sus áreas de aplicación principales y la diferencia en sus mercados objetivo.
- Según el tipo de prueba, el mercado de detección de salud de Asia y el Pacífico se segmenta en pruebas de colesterol, pruebas de diabetes, detección de cáncer, pruebas de revisión general, ETS, prueba de presión arterial y otras. En 2021, se espera que el segmento de pruebas de colesterol domine el mercado debido al aumento de la población geriátrica y el estilo de vida sedentario.
- Según el tipo de paquete, el mercado de exámenes de salud de Asia y el Pacífico se segmenta en exámenes de salud básicos, perfiles de personas mayores, exámenes de salud de mujeres, exámenes de salud de hombres, exámenes cardíacos, exámenes de diabetes y otros. En 2021, se espera que el segmento de exámenes de salud básicos domine el mercado debido al aumento del gasto en atención médica en los países asiáticos.
- Según el tipo de panel, el mercado de detección de enfermedades de Asia y el Pacífico se segmenta en paneles de múltiples pruebas y paneles de una sola prueba. En 2021, se espera que el segmento de paneles de múltiples pruebas domine el mercado debido al avance tecnológico de los laboratorios en esta región.
- Según el tipo de muestra, el mercado de detección de enfermedades de Asia y el Pacífico se segmenta en sangre, orina, suero, saliva y otros. En 2021, se espera que el segmento de sangre domine el mercado porque es el tipo de muestra más común y se puede diagnosticar en casi todos los laboratorios.
- En función de la tecnología, el mercado de detección de salud de Asia y el Pacífico está segmentado en inmunoensayos, imágenes médicas, QPCR (reacción en cadena de la polimerasa cuantitativa), Q-FISH (fluorescencia cuantitativa, hibridación in situ), TRF (fragmento de restricción terminal), STELA (análisis de longitud de telómero único) y otros. En 2021, se espera que el segmento de inmunoensayos domine el mercado porque el mercado asiático es uno de los mercados emergentes de la atención médica con un turismo médico en crecimiento que se espera que aumente la demanda de todas las técnicas de detección por este motivo.
- En función de las condiciones, el mercado de detección de enfermedades de Asia y el Pacífico se segmenta en enfermedades cardiovasculares, trastornos metabólicos, cáncer, afecciones inflamatorias, trastornos musculoesqueléticos, afecciones neurológicas, complicaciones de la hepatitis C, afecciones relacionadas con la inmunología y otras. En 2021, se espera que el segmento de enfermedades cardiovasculares domine el mercado debido a la alta prevalencia de enfermedades cardiovasculares en esta región también.
- Sobre la base de los sitios de recolección de muestras, el mercado de detección de salud de Asia-Pacífico se segmenta en hospitales, hogares, laboratorios de diagnóstico, oficinas y otros. En 2021, se espera que el segmento de hospitales domine el mercado a medida que la infraestructura está creciendo en la región de Asia-Pacífico con un número creciente de hospitales.
- En función del canal de distribución, el mercado de detección de enfermedades de Asia y el Pacífico se segmenta en licitaciones directas, ventas minoristas y otros. En 2021, se espera que el segmento de licitación directa domine el mercado debido al aumento de las ventas generales de programas de detección de enfermedades.
Análisis a nivel de país del mercado de detección de salud en Asia y el Pacífico
Se analiza el mercado de detección de salud de Asia y el Pacífico y se proporciona información sobre el tamaño del mercado según el tipo de prueba, el tipo de paquete, el tipo de panel, el tipo de muestra, la tecnología, la condición, los sitios de recolección de muestras y el canal de distribución.
Los países incluidos en el informe del mercado de detección de salud de Asia-Pacífico son Japón, China, Corea del Sur, India, Australia, Singapur, Tailandia, Malasia, Indonesia, Filipinas, Vietnam y el resto de Asia-Pacífico. Se espera que India en la región de Asia-Pacífico crezca con la tasa de crecimiento más alta en el período de pronóstico de 2021 a 2028 debido a la I+D innovadora y los lanzamientos y aprobaciones de nuevos productos.
La sección de países del informe también proporciona factores de impacto de mercado individuales y cambios en la regulación del mercado que afectan las tendencias actuales y futuras del mercado. Los puntos de datos como nuevas ventas, ventas de reemplazo, demografía del país, leyes regulatorias y aranceles de importación y exportación son algunos de los principales indicadores utilizados para pronosticar el escenario del mercado para países individuales. Además, la presencia y disponibilidad de marcas de Asia-Pacífico y sus desafíos enfrentados debido a la competencia grande o escasa de las marcas locales y nacionales, el impacto de los canales de venta se consideran al proporcionar un análisis de pronóstico de los datos del país.
El aumento de la población geriátrica y la mayor incidencia del cáncer y las enfermedades cardiovasculares impulsan el crecimiento del mercado de productos de detección de la salud en Asia y el Pacífico
El mercado de detección de salud de Asia y el Pacífico también le ofrece un análisis detallado del mercado para el crecimiento de cada país en la industria de productos de detección de salud con ventas de medicamentos, el impacto de los avances, la tecnología y los cambios en los escenarios regulatorios con su apoyo al mercado de detección de salud. Los datos están disponibles para el período histórico de 2010 a 2019.
Análisis del panorama competitivo y de la cuota de mercado de los servicios de detección de enfermedades en Asia y el Pacífico
El panorama competitivo del mercado de detección de salud de Asia-Pacífico proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, los sitios e instalaciones de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, las líneas de prueba de productos, las aprobaciones de productos, las patentes, la amplitud y amplitud de los productos, el dominio de las aplicaciones y la curva de la línea de vida de la tecnología. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de la empresa relacionado con el mercado de detección de salud de Asia-Pacífico.
Las principales empresas que operan en el mercado de detección de salud de Asia y el Pacífico son Sonic Healthcare Limited, Quest Diagnostics Incorporated, Healius Limited, Quidel Corporation, Eurofins Scientific, GRAIL, Exact Sciences Corporation, SYNLAB International GmbH, UNILABS, LabPLUS, BioReference Laboratories, ACM Global Laboratories, Cerba Healthcare, Innova Medical Group, AMEDES Holding GmbH, RadNet, Inc., Natera, Inc., Trinity Biotech, Nuffield Health, RepeatDx, NeoGenomics Laboratories, HU Group Holdings, Inc., Lifelabs, ARUP Laboratories, Q2 Solutions, Genova Diagnostics, Life Length, DNA Labs India, Telomere Diagnostics, Charles River Laboratories, Ambry Genetics, SpectraCell Laboratories, Inc., Dr. Lal PathLabs y Laboratory Corporation of America, entre otras.
Muchos lanzamientos y acuerdos de productos también son iniciados por empresas de todo el mundo, lo que también acelera el mercado de detección de salud en Asia y el Pacífico.
Por ejemplo,
- En marzo de 2020, Sonic Healthcare anunció que había adquirido Pathologie Hamburg, un laboratorio de patología. Esta adquisición ha proporcionado a la empresa mayores capacidades de producción y prueba. En septiembre de 2020, Healius Limited anunció que había firmado un acuerdo de venta con Virtus Health para adquirir Adora Fertility. Esto impulsará el mercado de la empresa en el período de pronóstico.
La colaboración, el lanzamiento de productos, la expansión comercial, los premios y reconocimientos, las empresas conjuntas y otras estrategias del actor del mercado están mejorando el mercado de la empresa en el mercado de detección de salud, lo que también brinda el beneficio para que la organización mejore su oferta de detección de salud.
SKU-
Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo
- Panel de análisis de datos interactivo
- Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
- Acceso de analista de investigación para personalización y consultas
- Análisis de la competencia con panel interactivo
- Últimas noticias, actualizaciones y análisis de tendencias
- Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Tabla de contenido
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA PACIFIC HEALTH SCREENING MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TEST TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 DISTRIBUTION CHANNELUSER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 REGULATIONS
5.1 WORLD HEALTH ORGANIZATION
5.2 NORTH AMERICA
5.3 EUROPE
6 INDUSTRIAL INSIGHTS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISING PREVALENCE OF CHRONIC DISEASES
7.1.2 GROWING GERIATRIC POPULATION
7.1.3 GOVERNMENT INITIATIVES UNDERTAKEN TO IMPLEMENT SCREENING PROGRAMS FOR VARIOUS DISEASES
7.1.4 RISING PER CAPITA INCOME AND HEALTHCARE EXPENDITURE
7.1.5 GRWOING NUMBER OF SCREENING PROGRAMS WORLDWIDE
7.2 RESTRAINTS
7.2.1 SCRACITY OF TECHNICALLY-SKILLED PROFESSIONALS
7.2.2 RISKS ASSOCIATED WITH SCREENING
7.2.3 LACK OF ACCESSIBILITY
7.3 OPPORTUNITIES
7.3.1 TECHNOLOGICAL ADVANCEMENTS IN HEALTH SCREENING
7.3.2 ACQUSITIONS AND MERGERS AMONG THE MARKET
7.3.3 NEW PRODUCT LAUNCHES IN THE MARKET
7.4 CHALLENGES
7.4.1 HIGHER COST OF HEALTH SCREENING
7.4.2 OPERATIONAL BARRIERS FACED IN CONDUCTING SCREENING TESTS
8 COVID-19 IMPACT ON ASIA PACIFIC HEALTH SCREENING MARKET
8.1 PRICE IMPACT
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY CHAIN
8.4 STRATEGIC DECISIONS FOR MANUFACTURERS
8.5 CONCLUSION
9 ASIA PACIFIC HEALTH SCREENING MARKET, BY TEST TYPE
9.1 OVERVIEW
9.2 CHOLESTEROL TESTS
9.2.1 TOTAL CHOLESTEROL TESTS
9.2.2 TRIGLYCERIDES
9.2.3 LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL
9.2.4 HIGH-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL
9.3 DIABETES TEST
9.3.1 FASTING/RANDOM BLOOD SUGAR TEST
9.3.2 A1C TEST
9.3.3 GLUCOSE TOLERANCE TEST
9.4 CANCER SCREENING
9.4.1 LIQUID BIOPSY
9.4.2 MAMMOGRAMS, OSTEOPOROSIS, BREAST MRI AND PAP SMEAR TESTS
9.4.3 LOW-DOSE HELICAL COMPUTED TOMOGRAPHY
9.4.4 COLORECTAL CANCER SCREENING TEST (STOOL TESTS, SIGMOIDOSCOPY, COLONOSCOPY, BLOOD-BASED DNA TEST, DOUBLE-CONTRAST BARIUM ENEMA (DCBE), AND SINGLE-SPECIMEN GFOBT)
9.4.5 PROSTATE SPECIFIC ANTIGEN (PSA) TEST
9.4.6 NEW-EARLY DETECTION CANCER TESTS
9.4.7 ALPHA FETOPROTEIN BLOOD TEST
9.4.8 CA-125 TEST
9.4.9 OTHERS
9.5 GENERAL CHECK UP TEST
9.5.1 REGULAR CHECK UP
9.5.1.1 REGULAR BLOOD TEST
9.5.1.2 X-RAYS
9.5.1.3 ECG
9.5.1.4 FECALYSIS
9.5.1.5 URINALYSIS
9.5.1.6 BMI
9.5.1.7 OTHERS
9.5.2 EYE CHECK UP
9.5.3 DENTAL TEST
9.5.4 HEARING TEST
9.6 STD’S
9.6.1 CHLAMYDIA
9.6.2 GONORRHEA
9.6.3 HPV
9.6.4 HIV
9.6.5 OTHERS
9.7 BLOOD PRESSURE TEST
9.8 OTHERS
9.8.1 LIVER FUNCTION TESTS
9.8.2 KIDNEY PROFILE
9.8.3 OTHERS
10 ASIA PACIFIC HEALTH SCREENING MARKET, BY PANEL TYPE
10.1 OVERVIEW
10.2 MULTI-TEST PANELS
10.3 SINGLE-TEST PANELS
10.3.1 INFLAMMATION TESTS
10.3.2 OXIDATIVE STRESS TESTS
10.3.3 HEAVY METAL TESTS
10.3.4 TELOMERE
11 ASIA PACIFIC HEALTH SCREENING MARKET, BY PACKAGE TYPE
11.1 OVERVIEW
11.2 BASIC HEALTH SCREENING
11.3 SENIOR CITIZEN PROFILE
11.4 WOMEN HEALTH CHECK
11.5 MEN HEALTH CHECK
11.6 HEART CHECK
11.7 DIABETES CHECK
11.8 OTHERS
12 ASIA PACIFIC HEALTH SCREENING MARKET, BY SAMPLE TYPE
12.1 OVERVIEW
12.2 BLOOD
12.3 URINE
12.4 SERUM
12.5 SALIVA
12.6 OTHERS
13 HEALTH SCREENING MARKET, BY TECHNOLOGY
13.1 OVERVIEW
13.2 IMMUNOASSAYS
13.3 MEDICAL IMAGING
13.4 QPCR
13.4.1 MMQPCR (MONOCHROME MULTIPLEX QPCR)
13.4.2 ATLQPCR (ABSOLUTE TELOMERE LENGTH QPCR)
13.5 Q-FISH
13.5.1 PRINS (PRIMED IN SITU SUBTYPE OF Q-FISH)
13.5.2 FLOW-FISH
13.5.3 HT Q-FISH (HIGH THROUGHPUT Q-FISH)
13.6 TRF (TERMINAL RESTRICTION FRAGMENT)
13.7 STELA (SINGLE TELOMERE LENGTH ANALYSIS)
13.8 OTHERS
14 ASIA PACIFIC HEALTH SCREENING MARKET, BY CONDITION
14.1 OVERVIEW
14.2 CARDIOVASCULAR DISEASE
14.2.1 CORONARY HEART DISEASE
14.2.2 ATHEROSCLEROSIS
14.3 METABOLIC DISORDERS
14.3.1 DIABETES MELLITUS
14.3.2 OBESITY
14.4 CANCER
14.5 INFLAMMATORY CONDITIONS
14.5.1 AUTOIMMUNE CONDITIONS
14.5.2 ALLERGIES
14.5.3 ARTHRITIS
14.5.4 ASTHMA
14.5.5 INFLAMMATORY DIGESTIVE PROBLEMS
14.6 MUSCULOSKELETAL DISORDERS
14.6.1 OSTEOPOROSIS
14.6.2 RHEUMATOID ARTHRITIS
14.7 NEUROLOGICAL CONDITIONS
14.7.1 CHRONIC STRESS
14.7.2 ALZHEIMER'S DISEASE
14.8 IMMUNOLOGY-RELATED CONDITIONS
14.9 HEPATITIS C COMPLICATIONS
14.1 OTHERS
15 HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL
15.1 OVERVIEW
15.2 DIRECT TENDERS
15.3 RETAIL SALES
15.4 OTHERS
16 ASIA PACIFIC HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES
16.1 OVERVIEW
16.2 HOSPITAL
16.2.1 ACUTE CARE HOSPITALS
16.2.2 LONG-TERM CARE HOSPITALS
16.2.3 NURSING FACILITIES
16.2.4 REHABILITATION CENTERS
16.3 HOME
16.4 DIAGNOSTIC LABORATORIES
16.5 OFFICES
16.6 OTHERS
17 ASIA PACIFIC HEALTH SCREENING MARKET, BY REGION
17.1 ASIA-PACIFIC
17.1.1 JAPAN
17.1.2 INDIA
17.1.3 SOUTH KOREA .
17.1.4 AUSTRALIA
17.1.5 SINGAPORE
17.1.6 THAILAND
17.1.7 MALAYSIA
17.1.8 INDONESIA
17.1.9 PHILIPPINES
17.1.10 REST OF ASIA-PACIFIC
18 ASIA PACIFIC HEALTH SCREENING MARKET: COMPANY LANDSCAPE
18.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
19 SWOT ANALYSIS
20 COMPANY PROFILE
20.1 QUEST DIAGNOSTICS INCORPORATED
20.1.1 COMPANY SNAPSHOT
20.1.2 REVENUE ANALYSIS
20.1.3 COMPANY SHARE ANALYSIS
20.1.4 PRODUCT PORTFOLIO
20.1.5 RECENT DEVELOPMENTS
20.2 SONIC HEALTHCARE LIMITED
20.2.1 COMPANY SNAPSHOT
20.2.2 REVENUE ANALYSIS
20.2.3 COMPANY SHARE ANALYSIS
20.2.4 PRODUCT PORTFOLIO
20.2.5 RECENT DEVELOPMENTS
20.3 LABORATORY CORPORATION OF AMERICA
20.3.1 COMPANY SNAPSHOT
20.3.2 REVENUE ANALYSIS
20.3.3 COMPANY SHARE ANALYSIS
20.3.4 PRODUCT PORTFOLIO
20.3.5 RECENT DEVELOPMENT
20.4 EUROFINS SCIENTIFIC
20.4.1 COMPANY SNAPSHOT
20.4.2 REVENUE ANALYSIS
20.4.3 COMPANY SHARE ANALYSIS
20.4.4 PRODUCT PORTFOLIO
20.4.5 RECENT DEVELOPMENTS
20.5 EXACT SCIENCES CORPORATION
20.5.1 COMPANY SNAPSHOT
20.5.2 REVENUE ANALYSIS
20.5.3 COMPANY SHARE ANALYSIS
20.5.4 PRODUCT PORTFOLIO
20.5.5 RECENT DEVELOPMENTS
20.6 ACM ASIA PACIFIC LABORATORIES
20.6.1 COMPANY SNAPSHOT
20.6.2 PRODUCT PORTFOLIO
20.6.3 RECENT DEVELOPMENT
20.7 AMEDES
20.7.1 COMPANY SNAPSHOT
20.7.2 PRODUCT PORTFOLIO
20.7.3 RECENT DEVELOPMENT
20.8 AMBRY GENETICS
20.8.1 COMPANY SNAPSHOT
20.8.2 SERVICE PORTFOLIO
20.8.3 RECENT DEVELOPMENTS
20.9 ARUP LABORATORIES
20.9.1 COMPANY SNAPSHOT
20.9.2 PRODUCT PORTFOLIO
20.9.3 RECENT DEVELOPMENTS
20.1 BIOREFRENCE LABORATORIES
20.10.1 COMPANY SNAPSHOT
20.10.2 REVENUE ANALYSIS
20.10.3 PRODUCT PORTFOLIO
20.10.4 RECENT DEVELOPMENTS
20.11 CHARLES RIVER
20.11.1 COMPANY SNAPSHOT
20.11.2 REVENUE ANALYSIS
20.11.3 PRODUCT PORTFOLIO
20.11.4 RECENT DEVELOPMENTS
20.12 CERBA HEALTHCARE
20.12.1 COMPANY SNAPSHOT
20.12.2 PRODUCT PORTFOLIO
20.12.3 RECENT DEVELOPMENT
20.13 DNA LABS INDIA
20.13.1 COMPANY SNAPSHOT
20.13.2 SERVICE PORTFOLIO
20.13.3 RECENT DEVELOPMENT
20.14 DR LAL PATH LABS
20.14.1 COMPANY SNAPSHOT
20.14.2 REVENUE ANALYSIS
20.14.3 PRODUCT PORTFOLIO
20.14.4 RECENT DEVELOPMENT
20.15 GENOVA DIGNOSTICS
20.15.1 COMPANY SNAPSHOT
20.15.2 SERVICE PORTFOLIO
20.15.3 RECENT DEVELOPMENT
20.16 GRAIL
20.16.1 COMPANY SNAPSHOT
20.16.2 SERVICE PORTFOLIO
20.16.3 RECENT DEVELOPMENTS
20.17 HEALIUS LIMITED
20.17.1 COMPANY SNAPSHOT
20.17.2 REVENUE ANALYSIS
20.17.3 PRODUCT PORTFOLIO
20.17.4 RECENT DEVELOPMENTS
20.18 H.U. GROUP HOLDINGS, INC.
20.18.1 COMPANY SNAPSHOT
20.18.2 REVENUE ANALYSIS
20.18.3 PRODUCT PORTFOLIO
20.18.4 RECENT DEVELOPMENTS
20.19 INNOVA MEDICAL GROUP
20.19.1 COMPANY SNAPSHOT
20.19.2 PRODUCT PORTFOLIO
20.19.3 RECENT DEVELOPMENT
20.2 LABPLUS
20.20.1 COMPANY SNAPSHOT
20.20.2 PRODUCT PORTFOLIO
20.20.3 RECENT DEVELOPMENT
20.21 LIFELABS
20.21.1 COMPANY SNAPSHOT
20.21.2 SERVICE PORTFOLIO
20.21.3 RECENT DEVELOPMENTS
20.22 LIFE LENGTH
20.22.1 COMPANY SNAPSHOT
20.22.2 SERVICE PORTFOLIO
20.22.3 RECENT DEVELOPMENT
20.23 NATERA, INC.
20.23.1 COMPANY SNAPSHOT
20.23.2 REVENUE ANALYSIS
20.23.3 PRODUCT PORTFOLIO
20.23.4 RECENT DEVELOPMENTS
20.24 NEOGENOMICS LABORATORIES
20.24.1 COMPANY SNAPSHOT
20.24.2 REVENUE ANALYSIS
20.24.3 PRODUCT PORTFOLIO
20.24.4 RECENT DEVELOPMENTS
20.25 NUFFIELD HEALTH
20.25.1 COMPANY SNAPSHOT
20.25.2 PRODUCT PORTFOLIO
20.25.3 RECENT DEVELOPMENT
20.26 Q2 SOLUTIONS
20.26.1 COMPANY SNAPSHOT
20.26.2 SERVICE PORTFOLIO
20.26.3 RECENT DEVELOPMENTS
20.27 QUIDEL CORPORATION
20.27.1 COMPANY SNAPSHOT
20.27.2 REVENUE ANALYSIS
20.27.3 PRODUCT PORTFOLIO
20.27.4 RECENT DEVELOPMENTS
20.28 REPEATDX
20.28.1 COMPANY SNAPSHOT
20.28.2 PRODUCT PORTFOLIO
20.28.3 RECENT DEVELOPMENT
20.29 SONIC HEALTHCARE LIMITED
20.29.1 COMPANY SNAPSHOT
20.29.2 REVENUE ANALYSIS
20.29.3 PRODUCT PORTFOLIO
20.29.4 RECENT DEVELOPMENTS
20.3 SPECTRACELL LABORATORIES, INC.
20.30.1 COMPANY SNAPSHOT
20.30.2 SERVICE PORTFOLIO
20.30.3 RECENT DEVELOPMENT
20.31 SYNLAB INTERNATIONAL GMBH
20.31.1 COMPANY SNAPSHOT
20.31.2 PRODUCT PORTFOLIO
20.31.3 RECENT DEVELOPMENT
20.32 TELOMERE DIAGNOSTICS
20.32.1 COMPANY SNAPSHOT
20.32.2 SERVICE PORTFOLIO
20.32.3 RECENT DEVELOPMENT
20.33 TRINITY BIOTECH
20.33.1 COMPANY SNAPSHOT
20.33.2 REVENUE ANALYSIS
20.33.3 PRODUCT PORTFOLIO
20.33.4 RECENT DEVELOPMENT
20.34 UNILABS
20.34.1 COMPANY SNAPSHOT
20.34.2 PRODUCT PORTFOLIO
20.34.3 RECENT DEVELOPMENT
21 QUESTIONNAIRE
22 RELATED REPORTS
Lista de Tablas
TABLE 1 NUMBER OF PEOPLE WITH DIABETES AMONG 20–79 YEARS OLD (IN MILLION)
TABLE 2 NEW CANCER CASES FOR AGE 85+ IN U.S.
TABLE 3 ACCORDING TO THE UNITED NATIONS, IN 2019, THE TOTAL POPULATION OF AGED PEOPLE ABOVE 65 WAS 703 MILLION AND IS EXPECTED TO REACH 1.5 BILLION BY 2050.
TABLE 4 PER CAPITA AMOUNTS: THE UNITED STATES (1960–2017)
TABLE 5 ASIA PACIFIC HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 6 ASIA PACIFIC CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 ASIA PACIFIC CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 8 ASIA PACIFIC DIABETES TEST IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 ASIA PACIFIC DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 10 ASIA PACIFIC CANCER SCREENING IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 ASIA PACIFIC CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 12 ASIA PACIFIC GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 ASIA PACIFIC GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 14 ASIA PACIFIC REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 15 ASIA PACIFIC STD’S IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 ASIA PACIFIC STD’S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 17 ASIA PACIFIC BLOOD PRESSURE TEST IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 20 ASIA PACIFIC HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 21 ASIA PACIFIC MULTI-TEST PANELS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 ASIA PACIFIC SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 ASIA PACIFIC SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 24 ASIA PACIFIC HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 25 ASIA PACIFIC BASIC HEALTH SCREENING IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 ASIA PACIFIC SENIOR CITIZEN PROFILE IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 ASIA PACIFIC WOMEN HEALTH CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 ASIA PACIFIC MEN HEALTH CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 ASIA PACIFIC HEART CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 ASIA PACIFIC DIABETES CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 ASIA PACIFIC HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
TABLE 33 ASIA PACIFIC BLOOD IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 ASIA PACIFIC URINE IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 ASIA PACIFIC SERUM IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 ASIA PACIFIC SALIVA IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 38 ASIA PACIFIC HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 39 ASIA PACIFIC IMMUNOASSAYS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 40 ASIA PACIFIC MEDICAL IMAGING IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 41 ASIA PACIFIC QPCR IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 42 ASIA PACIFIC QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 43 ASIA PACIFIC Q-FISH IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 44 ASIA PACIFIC Q-FISH IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 45 ASIA PACIFIC TRF (TERMINAL RESTRICTION FRAGMENT) IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 46 ASIA PACIFIC STELA (SINGLE TELOMERE LENGTH ANALYSIS) IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 47 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 48 ASIA PACIFIC HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 49 ASIA PACIFIC CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 50 ASIA PACIFIC CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 51 ASIA PACIFIC METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 52 ASIA PACIFIC METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 53 ASIA PACIFIC CANCER IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 54 ASIA PACIFIC INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 55 ASIA PACIFIC INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 56 ASIA PACIFIC MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 57 ASIA PACIFIC MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 58 ASIA PACIFIC NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 59 ASIA PACIFIC NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 60 ASIA PACIFIC IMMUNOLOGY-RELATED CONDITIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 61 ASIA PACIFIC HEPATITIS-C COMPLICATIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 62 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 63 ASIA PACIFIC HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 64 ASIA PACIFIC DIRECT TENDERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 65 ASIA PACIFIC RETAIL SALES IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 66 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 67 ASIA PACIFIC HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 68 ASIA PACIFIC HOSPITAL IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 69 ASIA PACIFIC HOSPITAL IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 70 ASIA PACIFIC HOME IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 71 ASIA PACIFIC DIAGNOSTIC LABORATORIES IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 72 ASIA PACIFIC OFFICES IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 73 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 74 ASIA-PACIFIC HEALTH SCREENING MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 75 ASIA-PACIFIC HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 76 ASIA-PACIFIC CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 77 ASIA-PACIFIC DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 78 ASIA-PACIFIC CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 79 ASIA-PACIFIC GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 80 ASIA-PACIFIC REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 81 ASIA-PACIFIC STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 82 ASIA-PACIFIC OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 83 ASIA-PACIFIC HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 84 ASIA-PACIFIC HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 85 ASIA-PACIFIC SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 86 ASIA-PACIFIC HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 87 ASIA-PACIFIC HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 88 ASIA-PACIFIC QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 89 ASIA-PACIFIC Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 90 ASIA-PACIFIC HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 91 ASIA-PACIFIC CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 92 ASIA-PACIFIC METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 93 ASIA-PACIFIC INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 94 ASIA-PACIFIC MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 95 ASIA-PACIFIC NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 96 ASIA-PACIFIC HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 97 ASIA-PACIFIC HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 98 ASIA-PACIFIC HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 99 CHINA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 100 CHINA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 101 CHINA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 102 CHINA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 103 CHINA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 104 CHINA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 105 CHINA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 106 CHINA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 107 CHINA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 108 CHINA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 109 CHINA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 110 CHINA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 111 CHINA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 112 CHINA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 113 CHINA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 114 CHINA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 115 CHINA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 116 CHINA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 117 CHINA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 118 CHINA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 119 CHINA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 120 CHINA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 121 CHINA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 122 CHINA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 123 JAPAN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 124 JAPAN CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 125 JAPAN DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 126 JAPAN CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 127 JAPAN GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 128 JAPAN REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 129 JAPAN STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 130 JAPAN OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 131 JAPAN HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 132 JAPAN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 133 JAPAN SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 134 JAPAN HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 135 JAPAN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 136 JAPAN QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 137 JAPAN Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 138 JAPAN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 139 JAPAN CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 140 JAPAN METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 141 JAPAN INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 142 JAPAN MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 143 JAPAN NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 144 JAPAN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 145 JAPAN HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 146 JAPAN HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 147 INDIA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 148 INDIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 149 INDIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 150 INDIA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 151 INDIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 152 INDIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 153 INDIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 154 INDIA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 155 INDIA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 156 INDIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 157 INDIA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 158 INDIA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 159 INDIA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 160 INDIA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 161 INDIA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 162 INDIA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 163 INDIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 164 INDIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 165 INDIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 166 INDIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 167 INDIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 168 INDIA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 169 INDIA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 170 INDIA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 171 SOUTH KOREA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 172 SOUTH KOREA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 173 SOUTH KOREA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 174 SOUTH KOREA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 175 SOUTH KOREA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 176 SOUTH KOREA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 177 SOUTH KOREA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 178 SOUTH KOREA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 179 SOUTH KOREA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 180 SOUTH KOREA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 181 SOUTH KOREA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 182 SOUTH KOREA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 183 SOUTH KOREA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 184 SOUTH KOREA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 185 SOUTH KOREA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 186 SOUTH KOREA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 187 SOUTH KOREA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 188 SOUTH KOREA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 189 SOUTH KOREA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 190 SOUTH KOREA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 191 SOUTH KOREA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 192 SOUTH KOREA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 193 SOUTH KOREA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 194 SOUTH KOREA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 195 AUSTRALIA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 196 AUSTRALIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 197 AUSTRALIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 198 AUSTRALIA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 199 AUSTRALIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 200 AUSTRALIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 201 AUSTRALIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 202 AUSTRALIA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 203 AUSTRALIA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 204 AUSTRALIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 205 AUSTRALIA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 206 AUSTRALIA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 207 AUSTRALIA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 208 AUSTRALIA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 209 AUSTRALIA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 210 AUSTRALIA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 211 AUSTRALIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 212 AUSTRALIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 213 AUSTRALIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 214 AUSTRALIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 215 AUSTRALIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 216 AUSTRALIA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 217 AUSTRALIA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 218 AUSTRALIA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 219 SINGAPORE HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 220 SINGAPORE CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 221 SINGAPORE DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 222 SINGAPORE CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 223 SINGAPORE GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 224 SINGAPORE REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 225 SINGAPORE STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 226 SINGAPORE OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 227 SINGAPORE HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 228 SINGAPORE HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 229 SINGAPORE SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 230 SINGAPORE HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 231 SINGAPORE HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 232 SINGAPORE QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 233 SINGAPORE Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 234 SINGAPORE HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 235 SINGAPORE CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 236 SINGAPORE METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 237 SINGAPORE INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 238 SINGAPORE MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 239 SINGAPORE NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 240 SINGAPORE HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 241 SINGAPORE HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 242 SINGAPORE HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 243 THAILAND HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 244 THAILAND CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 245 THAILAND DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 246 THAILAND CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 247 THAILAND GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 248 THAILAND REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 249 THAILAND STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 250 THAILAND OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 251 THAILAND HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 252 THAILAND HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 253 THAILAND SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 254 THAILAND HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 255 THAILAND HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 256 THAILAND QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 257 THAILAND Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 258 THAILAND HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 259 THAILAND CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 260 THAILAND METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 261 THAILAND INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 262 THAILAND MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 263 THAILAND NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 264 THAILAND HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 265 THAILAND HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 266 THAILAND HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 267 MALAYSIA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 268 MALAYSIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 269 MALAYSIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 270 MALAYSIA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 271 MALAYSIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 272 MALAYSIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 273 MALAYSIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 274 MALAYSIA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 275 MALAYSIA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 276 MALAYSIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 277 MALAYSIA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 278 MALAYSIA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 279 MALAYSIA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 280 MALAYSIA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 281 MALAYSIA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 282 MALAYSIA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 283 MALAYSIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 284 MALAYSIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 285 MALAYSIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 286 MALAYSIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 287 MALAYSIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 288 MALAYSIA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 289 MALAYSIA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 290 MALAYSIA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 291 INDONESIA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 292 INDONESIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 293 INDONESIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 294 INDONESIA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 295 INDONESIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 296 INDONESIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 297 INDONESIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 298 INDONESIA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 299 INDONESIA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 300 INDONESIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 301 INDONESIA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 302 INDONESIA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 303 INDONESIA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 304 INDONESIA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 305 INDONESIA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 306 INDONESIA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 307 INDONESIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 308 INDONESIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 309 INDONESIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 310 INDONESIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 311 INDONESIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 312 INDONESIA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 313 INDONESIA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 314 INDONESIA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 315 PHILIPPINES HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 316 PHILIPPINES CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 317 PHILIPPINES DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 318 PHILIPPINES CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 319 PHILIPPINES GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 320 PHILIPPINES REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 321 PHILIPPINES STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 322 PHILIPPINES OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 323 PHILIPPINES HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 324 PHILIPPINES HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 325 PHILIPPINES SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 326 PHILIPPINES HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 327 PHILIPPINES HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 328 PHILIPPINES QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 329 PHILIPPINES Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 330 PHILIPPINES HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 331 PHILIPPINES CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 332 PHILIPPINES METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 333 PHILIPPINES INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 334 PHILIPPINES MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 335 PHILIPPINES NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 336 PHILIPPINES HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 337 PHILIPPINES HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 338 PHILIPPINES HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 339 REST OF ASIA-PACIFIC HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
Lista de figuras
FIGURE 1 ASIA PACIFIC HEALTH SCREENING MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC HEALTH SCREENING MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC HEALTH SCREENING MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC HEALTH SCREENING MARKET : ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC HEALTH SCREENING MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC HEALTH SCREENING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC HEALTH SCREENING MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA PACIFIC HEALTH SCREENING MARKET: MARKET DISTRIBUTION CHANNEL COVERAGE GRID
FIGURE 9 ASIA PACIFIC HEALTH SCREENING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC HEALTH SCREENING MARKET: SEGMENTATION
FIGURE 11 HIGH PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE ASIA PACIFIC HEALTH SCREENING MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 CHOLESTROL TESTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC HEALTH SCREENING MARKET IN 2021 & 2028
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE ASIA PACIFIC HEALTH SCREENING MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA PACIFIC HEALTH SCREENING MARKET
FIGURE 15 PREVALENCE OF CHRONIC DISEASES
FIGURE 16 AGING POPULATION IN THE WORLD (IN MILLION)
FIGURE 17 NORTH AMERICA AGING POPULATION (IN MILLION)
FIGURE 18 EUROPE AGING POPULATION (IN MILLION)
FIGURE 19 ASIA-PACIFIC AGING POPULATION (IN MILLION)
FIGURE 20 ASIA PACIFIC HEALTH SCREENING MARKET: BY TEST TYPE, 2020
FIGURE 21 ASIA PACIFIC HEALTH SCREENING MARKET: BY TEST TYPE, 2021-2028 (USD MILLION)
FIGURE 22 ASIA PACIFIC HEALTH SCREENING MARKET: BY TEST TYPE, CAGR (2021-2028)
FIGURE 23 ASIA PACIFIC HEALTH SCREENING MARKET: BY TEST TYPE, LIFELINE CURVE
FIGURE 24 ASIA PACIFIC HEALTH SCREENING MARKET: BY PANEL TYPE, 2020
FIGURE 25 ASIA PACIFIC HEALTH SCREENING MARKET: BY PANEL TYPE, 2021-2028 (USD MILLION)
FIGURE 26 ASIA PACIFIC HEALTH SCREENING MARKET: BY PANEL TYPE, CAGR (2021-2028)
FIGURE 27 ASIA PACIFIC HEALTH SCREENING MARKET: BY PANEL TYPE, LIFELINE CURVE
FIGURE 28 ASIA PACIFIC HEALTH SCREENING MARKET: BY PACKAGE TYPE, 2020
FIGURE 29 ASIA PACIFIC HEALTH SCREENING MARKET: BY PACKAGE TYPE, 2021-2028 (USD MILLION)
FIGURE 30 ASIA PACIFIC HEALTH SCREENING MARKET: BY PACKAGE TYPE, CAGR (2021-2028)
FIGURE 31 ASIA PACIFIC HEALTH SCREENING MARKET: BY PACKAGE TYPE, LIFELINE CURVE
FIGURE 32 ASIA PACIFIC HEALTH SCREENING MARKET: BY SAMPLE TYPE, 2020
FIGURE 33 ASIA PACIFIC HEALTH SCREENING MARKET: BY SAMPLE TYPE, 2021-2028 (USD MILLION)
FIGURE 34 ASIA PACIFIC HEALTH SCREENING MARKET: BY SAMPLE TYPE, CAGR (2021-2028)
FIGURE 35 ASIA PACIFIC HEALTH SCREENING MARKET: BY SAMPLE TYPE, LIFELINE CURVE
FIGURE 36 ASIA PACIFIC HEALTH SCREENING MARKET: BY TECHNOLOGY, 2020
FIGURE 37 ASIA PACIFIC HEALTH SCREENING MARKET: BY TECHNOLOGY, 2021-2028 (USD MILLION)
FIGURE 38 ASIA PACIFIC HEALTH SCREENING MARKET: BY TECHNOLOGY, CAGR (2021-2028)
FIGURE 39 ASIA PACIFIC HEALTH SCREENING MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 40 ASIA PACIFIC HEALTH SCREENING MARKET: BY CONDITION, 2020
FIGURE 41 ASIA PACIFIC HEALTH SCREENING MARKET: BY CONDITION, 2021-2028 (USD MILLION)
FIGURE 42 ASIA PACIFIC HEALTH SCREENING MARKET: BY CONDITION, CAGR (2021-2028)
FIGURE 43 ASIA PACIFIC HEALTH SCREENING MARKET: BY CONDITION, LIFELINE CURVE
FIGURE 44 ASIA PACIFIC HEALTH SCREENING MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 45 ASIA PACIFIC HEALTH SCREENING MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 46 ASIA PACIFIC HEALTH SCREENING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 47 ASIA PACIFIC HEALTH SCREENING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 48 ASIA PACIFIC HEALTH SCREENING MARKET: BY SAMPLE COLLECTION SITES, 2020
FIGURE 49 ASIA PACIFIC HEALTH SCREENING MARKET: BY SAMPLE COLLECTION SITES, 2021-2028 (USD MILLION)
FIGURE 50 ASIA PACIFIC HEALTH SCREENING MARKET: BY SAMPLE COLLECTION SITES, CAGR (2021-2028)
FIGURE 51 ASIA PACIFIC HEALTH SCREENING MARKET: BY SAMPLE COLLECTION SITES, LIFELINE CURVE
FIGURE 52 ASIA-PACIFIC HEALTH SCREENING MARKET: SNAPSHOT (2020)
FIGURE 53 ASIA-PACIFIC HEALTH SCREENING MARKET: BY COUNTRY (2020)
FIGURE 54 ASIA-PACIFIC HEALTH SCREENING MARKET: BY COUNTRY (2021 & 2028)
FIGURE 55 ASIA-PACIFIC HEALTH SCREENING MARKET: BY COUNTRY (2020 & 2028)
FIGURE 56 ASIA-PACIFIC HEALTH SCREENING MARKET: BY TEST TYPE (2021-2028)
FIGURE 57 ASIA PACIFIC HEALTH SCREENING MARKET: COMPANY SHARE 2020(%)
Metodología de investigación
La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.
La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.
Personalización disponible
Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.
